2007
DOI: 10.1016/j.ejcts.2007.01.045
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea☆

Abstract: Taken together, these results demonstrated that the built-in perfusion system within DegraPol scaffolds was able to maintain an intact tracheal epithelial layer, allowed a continuous delivery of cells, and kept an efficient VEGF/VPF expression level which accelerated angiogenic response in the CAM assay. This design combines the in vitro and in vivo parts of tissue engineering and offers the possibility to be used as an in vivo bioreactor implanted for the tissue-engineered reconstruction of trachea and of oth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 44 publications
(29 citation statements)
references
References 25 publications
0
28
0
Order By: Relevance
“…64 The engineered autologous cell sheets can not only be used in clinical settings, but they can also be transferred to implant surfaces as epithelium for tissue replacement. 65 However, a major disadvantage of the cell sheet methodology is the time-consuming procedure to create a robust structure for transplantation and the difficulties in handling the sheets.…”
Section: Epithelium In Clinical Tissue-engineering Applicationsmentioning
confidence: 99%
“…64 The engineered autologous cell sheets can not only be used in clinical settings, but they can also be transferred to implant surfaces as epithelium for tissue replacement. 65 However, a major disadvantage of the cell sheet methodology is the time-consuming procedure to create a robust structure for transplantation and the difficulties in handling the sheets.…”
Section: Epithelium In Clinical Tissue-engineering Applicationsmentioning
confidence: 99%
“…If successful, such bioreactors are believed to clear the way for the generation of clinically applicable, tissue engineered constructs tailored with respect to the required size and shape in vitro. In various fields of hollow organ tissue engineering, such as of the cardiovascular system (Song et al, 2011;Iyer et al, 2011), as well as the respiratory (Tan et al, 2007) and genitourinary tract (Wei et al, 2011) the rapidly growing know-how on bioreactor design and manufacturing has ultimately enhanced their more and more frequent use. The increasing application of these devices has not yet been parallelled in gastrointestinal tissue engineering.…”
Section: Bioreactorsmentioning
confidence: 99%
“…The continuous perfusion of the tubular biodegradable scaffolds coincided with an adequate epithelialization of the constructs and an accelerated vascularization in the chorioallantois membrane assay. The authors assumed that the concept of the in vivo bioreactor allows a more physiological process in the reconstruction of tissues and that better initial conditions are granted for the problem so far not solved, the vascularization of tracheal scaffolds [106] .…”
Section: Vascular Supply Of Tracheal Constructsmentioning
confidence: 99%